EPCAM and hepatocellular carcinoma: The platform with dual labeling of EpCAM and ASGPR had an effective ability in detecting HCC CTCs. CTCs were identified in 100% of HCC patients. Total CTCs and non-epithelial CTCs were associated with advanced stage and malignant progression. Zhu et al., 2020 (53)